Home› Europe› EEA Joint Committee› Decision of the EEA Joint Committee No 208/2021 of 9 July 20...
Date: 8-Feb-2024 Category: Not Applicable State: Union Government Country: Europe

Decision of the EEA Joint Committee No 208/2021 of 9 July 2021 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/303]

Issued by EEA Joint Committee · Not Applicable

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task

Executive Summary & Key Takeaways

What it means

  • The Decision of the EEA Joint Committee No 208/2021 amends Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement to incorporate two Commission Implementing Regulations: (EU) 2020/1643 and (EU) 2020/2087.

Key Changes

  • Commission Implementing Regulation (EU) 2020/1643, amending Implementing Regulation (EU) No 540/2011, is incorporated into the EEA Agreement. This regulation concerns the approval periods of active substances including calcium phosphide, denathonium benzoate, haloxyfop-P, imidacloprid, pencycuron and zeta-cypermethrin.
  • Commission Implementing Regulation (EU) 2020/2087, concerning the non-renewal of the approval of the active substance mancozeb, is incorporated into the EEA Agreement. This regulation amends the Annex to Commission Implementing Regulation (EU) No 540/2011.
  • Chapter XV of Annex II to the EEA Agreement is amended to include references to Implementing Regulations (EU) 2020/1643 and (EU) 2020/2087.

Impact Analysis

Businesses involved in plant protection products

  • Businesses operating within the EEA need to ensure compliance with the updated regulations regarding plant protection products.

EEA Member States

  • National authorities responsible for plant protection products need to update their approval processes and communicate these changes to relevant stakeholders.

Action Items

  • Ensure compliance with the updated regulations for placing plant protection products on the market within the EEA.

Key Entities Referenced

EEA Joint Committee: The decision-making body responsible for amending the EEA Agreement. Commission Implementing Regulation (EU) 2020/1643: Regulation amending Implementing Regulation (EU) No 540/2011 regarding the approval periods of certain active substances. Commission Implementing Regulation (EU) 2020/2087: Regulation concerning the non-renewal of the approval of the active substance mancozeb. Regulation (EC) No 1107/2009: Regulation of the European Parliament and of the Council concerning the placing of plant protection products on the market. Commission Implementing Regulation (EU) No 540/2011: Regulation implementing Regulation (EC) No 1107/2009 as regards the list of approved active substances. EEA Agreement: Agreement on the European Economic Area.
Official Source Record View Original Source →
See Full Document Text
Official Journal EN of the European Union L series 2024/303 8.2.2024 DECISION OF THE EEA JOINT COMMITTEE No 208/2021 of 9 July 2021 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/303] THE EEA JOINT COMMITTEE, Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof, Whereas: (1) Commission Implementing Regulation (EU) 2020/1643 of 5 November 2020amending Implementing Regulation (EU) No 540/2011 as regards the approval periods of the active substances calcium phosphide, denathonium benzoate, haloxyfop-P, imidacloprid, pencycuron and zeta-cypermethrin(1) is to be incorporated into the EEA Agreement. (2) Commission Implementing Regulation (EU) 2020/2087 of 14 December 2020concerning the non-renewal of the approval of the active substance mancozeb, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011(2) is to be incorporated into the EEA Agreement. (3) Annex II to the EEA Agreement should therefore be amended accordingly, HAS ADOPTED THIS DECISION: Article 1 Chapter XV of Annex II to the EEA Agreement shall be amended as follows: 1. The following indents are added in point 13a (Commission Implementing Regulation (EU) No 540/2011): ‘- 32020 R 1643: Commission Implementing Regulation (EU) 2020/1643 of 5 November 2020(OJ L 370, 6.11.2020, p. 18), - 32020 R 2087: Commission Implementing Regulation (EU) 2020/2087 of 14 December 2020 (OJ L 423, 15.12.2020, p. 50).’ 2. The following point is inserted after point 13zzzzzzzzzzzg (Commission Implementing Regulation (EU) 2020/1498): ‘13zzzzzzzzzzzh. 32020 R 2087: Commission Implementing Regulation (EU) 2020/2087 of 14 December 2020 concerning the non-renewal of the approval of the active substance mancozeb, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 423, 15.12.2020, p. 50).’ Article 2 The texts of Implementing Regulations (EU) 2020/1643 and (EU) 2020/2087 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic. (1) OJ L 370, 6.11.2020, p. 18. (2) OJ L 423, 15.12.2020, p. 50. ELI: http://data.europa.eu/eli/dec/2024/303/oj 1/2EN OJ L, 8.2.2024 Article 3 This Decision shall enter into force on 10 July 2021, provided that all the notifications under Article 103(1) of the EEA Agreement have been made*. Article 4 This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union. Done at Brussels, 9 July 2021. For the EEA Joint Committee The President Rolf EINAR FIFE * No constitutional requirements indicated. 2/2 ELI: http://data.europa.eu/eli/dec/2024/303/oj

Continue your research

Related Documents from EEA Joint Committee